204 related articles for article (PubMed ID: 17175556)
1. In vitro and in vivo evaluation of the estrogenic, androgenic, and progestagenic potential of two cyclic siloxanes.
Quinn AL; Regan JM; Tobin JM; Marinik BJ; McMahon JM; McNett DA; Sushynski CM; Crofoot SD; Jean PA; Plotzke KP
Toxicol Sci; 2007 Mar; 96(1):145-53. PubMed ID: 17175556
[TBL] [Abstract][Full Text] [Related]
2. Lack of (anti-) androgenic or estrogenic effects of three pyrethroids (esfenvalerate, fenvalerate, and permethrin) in the Hershberger and uterotrophic assays.
Kunimatsu T; Yamada T; Ose K; Sunami O; Kamita Y; Okuno Y; Seki T; Nakatsuka I
Regul Toxicol Pharmacol; 2002 Apr; 35(2 Pt 1):227-37. PubMed ID: 12052007
[TBL] [Abstract][Full Text] [Related]
3. Assessment of estrogenic and androgenic activities of tetramethrin in vitro and in vivo assays.
Kim SS; Kwack SJ; Lee RD; Lim KJ; Rhee GS; Seok JH; Kim BH; Won YH; Lee GS; Jeung EB; Lee BM; Park KL
J Toxicol Environ Health A; 2005 Dec; 68(23-24):2277-89. PubMed ID: 16326440
[TBL] [Abstract][Full Text] [Related]
4. Potential estrogenic and antiestrogenic activity of the cyclic siloxane octamethylcyclotetrasiloxane (D4) and the linear siloxane hexamethyldisiloxane (HMDS) in immature rats using the uterotrophic assay.
McKim JM; Wilga PC; Breslin WJ; Plotzke KP; Gallavan RH; Meeks RG
Toxicol Sci; 2001 Sep; 63(1):37-46. PubMed ID: 11509742
[TBL] [Abstract][Full Text] [Related]
5. Examination of the in vitro and in vivo estrogenic activities of eight commercial phthalate esters.
Zacharewski TR; Meek MD; Clemons JH; Wu ZF; Fielden MR; Matthews JB
Toxicol Sci; 1998 Dec; 46(2):282-93. PubMed ID: 10048131
[TBL] [Abstract][Full Text] [Related]
6. Hydroxylated polychlorinated biphenyls (PCBs) as estrogens and antiestrogens: structure-activity relationships.
Connor K; Ramamoorthy K; Moore M; Mustain M; Chen I; Safe S; Zacharewski T; Gillesby B; Joyeux A; Balaguer P
Toxicol Appl Pharmacol; 1997 Jul; 145(1):111-23. PubMed ID: 9221830
[TBL] [Abstract][Full Text] [Related]
7. In vivo and in vitro estrogenic activity of the antidepressant fluoxetine.
Müller JC; Imazaki PH; Boareto AC; Lourenço EL; Golin M; Vechi MF; Lombardi NF; Minatovicz BC; Scippo ML; Martino-Andrade AJ; Dalsenter PR
Reprod Toxicol; 2012 Aug; 34(1):80-5. PubMed ID: 22522098
[TBL] [Abstract][Full Text] [Related]
8. The pyrethroid metabolites 3-phenoxybenzoic acid and 3-phenoxybenzyl alcohol do not exhibit estrogenic activity in the MCF-7 human breast carcinoma cell line or Sprague-Dawley rats.
Laffin B; Chavez M; Pine M
Toxicology; 2010 Jan; 267(1-3):39-44. PubMed ID: 19853000
[TBL] [Abstract][Full Text] [Related]
9. Analysis of the interaction of phytoestrogens and synthetic chemicals: an in vitro/in vivo comparison.
Charles GD; Gennings C; Tornesi B; Kan HL; Zacharewski TR; Bhaskar Gollapudi B; Carney EW
Toxicol Appl Pharmacol; 2007 Feb; 218(3):280-8. PubMed ID: 17222880
[TBL] [Abstract][Full Text] [Related]
10. Lack of estrogenic or (anti-)androgenic effects of d-phenothrin in the uterotrophic and Hershberger assays.
Yamada T; Ueda S; Yoshioka K; Kawamura S; Seki T; Okuno Y; Mikami N
Toxicology; 2003 Apr; 186(3):227-39. PubMed ID: 12628315
[TBL] [Abstract][Full Text] [Related]
11. Chlropyrifos-methyl shows anti-androgenic activity without estrogenic activity in rats.
Kang HG; Jeong SH; Cho JH; Kim DG; Park JM; Cho MH
Toxicology; 2004 Jul; 199(2-3):219-30. PubMed ID: 15147795
[TBL] [Abstract][Full Text] [Related]
12. Comparison of in vitro and in vivo screening models for androgenic and estrogenic activities.
Sonneveld E; Riteco JA; Jansen HJ; Pieterse B; Brouwer A; Schoonen WG; van der Burg B
Toxicol Sci; 2006 Jan; 89(1):173-87. PubMed ID: 16221957
[TBL] [Abstract][Full Text] [Related]
13. Interaction of polycyclic musks and UV filters with the estrogen receptor (ER), androgen receptor (AR), and progesterone receptor (PR) in reporter gene bioassays.
Schreurs RH; Sonneveld E; Jansen JH; Seinen W; van der Burg B
Toxicol Sci; 2005 Feb; 83(2):264-72. PubMed ID: 15537743
[TBL] [Abstract][Full Text] [Related]
14. Estrogenic and anti-androgenic activities of 4-nitrophenol in diesel exhaust particles.
Li C; Taneda S; Suzuki AK; Furuta C; Watanabe G; Taya K
Toxicol Appl Pharmacol; 2006 Nov; 217(1):1-6. PubMed ID: 16884752
[TBL] [Abstract][Full Text] [Related]
15. Octamethylcyclotetrasiloxane exhibits estrogenic activity in mice via ERalpha.
He B; Rhodes-Brower S; Miller MR; Munson AE; Germolec DR; Walker VR; Korach KS; Meade BJ
Toxicol Appl Pharmacol; 2003 Nov; 192(3):254-61. PubMed ID: 14575643
[TBL] [Abstract][Full Text] [Related]
16. A comparison of in vitro and in vivo EDSTAC test battery results for detecting antiandrogenic activity.
Charles GD; Kan HL; Schisler MR; Bhaskar Gollapudi B; Sue Marty M
Toxicol Appl Pharmacol; 2005 Jan; 202(1):108-20. PubMed ID: 15589981
[TBL] [Abstract][Full Text] [Related]
17. Toxicology and humoral immunity assessment of decamethylcyclopentasiloxane (D5) following a 1-month whole body inhalation exposure in Fischer 344 rats.
Burns-Naas LA; Mast RW; Klykken PC; McCay JA; White KL; Mann PC; Naas DJ
Toxicol Sci; 1998 May; 43(1):28-38. PubMed ID: 9629617
[TBL] [Abstract][Full Text] [Related]
18. Attenuation of estrogenic effects by dihydrotestosterone in the pig uterus is associated with downregulation of the estrogen receptors.
Cárdenas H; Pope WF
Biol Reprod; 2004 Feb; 70(2):297-302. PubMed ID: 14522825
[TBL] [Abstract][Full Text] [Related]
19. In vivo estrogenic potential of 4-methyl-2,4-bis(4-hydroxyphenyl)pent-1-ene, an active metabolite of bisphenol A, in uterus of ovariectomized rat.
Okuda K; Takiguchi M; Yoshihara S
Toxicol Lett; 2010 Aug; 197(1):7-11. PubMed ID: 20435109
[TBL] [Abstract][Full Text] [Related]
20. A two-generation reproductive toxicity study of octamethylcyclotetrasiloxane (D4) in rats exposed by whole-body vapor inhalation.
Siddiqui WH; Stump DG; Plotzke KP; Holson JF; Meeks RG
Reprod Toxicol; 2007 Feb; 23(2):202-15. PubMed ID: 17223010
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
